Bile Acid as Therapeutic Agents

2017 ◽  
pp. 61-90 ◽  
Author(s):  
Yoshihide Yamanashi ◽  
Tappei Takada ◽  
Hiroshi Suzuki
Keyword(s):  
Molecules ◽  
2020 ◽  
Vol 26 (1) ◽  
pp. 25
Author(s):  
Maria Luisa Navacchia ◽  
Elena Marchesi ◽  
Daniela Perrone

The advantages of a treatment modality that combines two or more therapeutic agents in cancer therapy encourages the study of hybrid functional compounds for pharmacological applications. In light of this, we reviewed recent works on hybrid molecules based on bile acids. Due to their biological properties, as well as their different chemical/biochemical reactive moieties, bile acids can be considered very interesting starting molecules for conjugation with natural or synthetic bioactive molecules.


2016 ◽  
Vol 13 (8) ◽  
pp. 1133-1148 ◽  
Author(s):  
Célia Faustino ◽  
Cláudia Serafim ◽  
Patrícia Rijo ◽  
Catarina Pinto Reis

2020 ◽  
Vol 56 (65) ◽  
pp. 9332-9335
Author(s):  
Sandra Estalayo-Adrián ◽  
Salvador Blasco ◽  
Sandra A. Bright ◽  
Gavin J. McManus ◽  
Guillermo Orellana ◽  
...  

Two new water-soluble amphiphilic Ru(ii) polypyridyl complexes were synthesised and their photophysical and photobiological properties evaluated; both complexes showed a rapid cellular uptake and phototoxicity against HeLa cervical cancer cells.


2020 ◽  
Vol 134 (12) ◽  
pp. 1403-1432 ◽  
Author(s):  
Manal Muin Fardoun ◽  
Dina Maaliki ◽  
Nabil Halabi ◽  
Rabah Iratni ◽  
Alessandra Bitto ◽  
...  

Abstract Flavonoids are polyphenolic compounds naturally occurring in fruits and vegetables, in addition to beverages such as tea and coffee. Flavonoids are emerging as potent therapeutic agents for cardiovascular as well as metabolic diseases. Several studies corroborated an inverse relationship between flavonoid consumption and cardiovascular disease (CVD) or adipose tissue inflammation (ATI). Flavonoids exert their anti-atherogenic effects by increasing nitric oxide (NO), reducing reactive oxygen species (ROS), and decreasing pro-inflammatory cytokines. In addition, flavonoids alleviate ATI by decreasing triglyceride and cholesterol levels, as well as by attenuating inflammatory mediators. Furthermore, flavonoids inhibit synthesis of fatty acids and promote their oxidation. In this review, we discuss the effect of the main classes of flavonoids, namely flavones, flavonols, flavanols, flavanones, anthocyanins, and isoflavones, on atherosclerosis and ATI. In addition, we dissect the underlying molecular and cellular mechanisms of action for these flavonoids. We conclude by supporting the potential benefit for flavonoids in the management or treatment of CVD; yet, we call for more robust clinical studies for safety and pharmacokinetic values.


2001 ◽  
Vol 120 (5) ◽  
pp. A1-A1
Author(s):  
G ALPINI ◽  
S GLASER ◽  
J PHINIZY ◽  
N KANNO ◽  
H FRANCIS ◽  
...  

2009 ◽  
Vol 47 (05) ◽  
Author(s):  
J Maléth ◽  
Z Rakonczay ◽  
V Venglovecz ◽  
Z Rázga ◽  
L Tiszlavicz ◽  
...  

2014 ◽  
Vol 52 (01) ◽  
Author(s):  
M Rau ◽  
J Schmitt ◽  
T Kudlich ◽  
JJG Marin ◽  
M Rodríguez Romero ◽  
...  
Keyword(s):  

2015 ◽  
Vol 53 (12) ◽  
Author(s):  
C Chintalapati ◽  
C Wöhler ◽  
C Ehlting ◽  
J Bode ◽  
D Häussinger ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document